Excessive regulation creates a "guilty until proven innocent" environment that stifles innovation in physical and medical industries. By treating compliance as a bottleneck, current systems force engineers to spend months on rote documentation, preventing rapid iteration. AI offers a potential path forward by automating regulatory tasks, though this risks creating "agent-on-agent" bureaucratic wars. In healthcare, the lack of a true private market and the asymmetric nature of regulatory risk—where officials are punished for approving bad outcomes but never for blocking good ones—further prevents technological growth. Addressing these barriers requires shifting toward enforcement-based models, establishing "innovation zones" for experimentation, and introducing private payment mechanisms to create the competitive feedback loops necessary for cost reduction and quality improvement.
Sign in to continue reading, translating and more.
Open full episode in Podwise